Advertisement

FDA Aims To Be 'Nimble' On COVID-19 Vaccine Changes For Variants

Acting FDA Commissioner Janet Woodcock said the agency would likely hold advisory panel meetings to consider changes in COVID-19 vaccines made in response to coronavirus variants. (NPR)
Acting FDA Commissioner Janet Woodcock said the agency would likely hold advisory panel meetings to consider changes in COVID-19 vaccines made in response to coronavirus variants. (NPR)

Related:

Advertisement

More from WBUR

Listen Live
Close